Alcyone Therapeutics
Lowell
About Alcyone Therapeutics
Alcyone Therapeutics is Pioneering Next-Generation Precision CNS Genetic Therapies to unlock new possibilities and overcome challenges for CNS therapy development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $23.0M
- Funding stage: M&A
- Last round: Corporate Round (Apr 2025)
- Website: alcyonetx.com
- Phone: (978) 709-1946
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/alcyone-therapeutics-5089 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.